This document discusses neonatal surgical emergencies and anesthetic management considerations. It covers the physiological differences of the neonatal system including the cardiovascular, respiratory, renal and thermal regulation systems. It emphasizes the importance of maintaining normothermia, oxygenation, hydration and glucose levels. The document provides guidance on optimization, monitoring, induction, intubation, maintenance and recovery for neonatal anesthesia. Special attention is needed in the postoperative period to prevent complications like apnea, laryngospasm and cardiac arrest.
Presentation of Dr. Dean Hess at 10th Pulmonary Medicine Update Course, Cairo, Egypt. Pulmonary Medicine Update Course is organized by Scribe : www.scribeofegypt.com
Introduction of organ donation .
Introduction of brain death and pathophysiology following it.
Perioperative problems in organ retrieval .
Goals of management of these patients .
Anesthetic management of the cadaver during organ harvesting.
This gives a brief idea about the:
Techniques, Response To NIV, Clinical indications, Contraindications and Evidence Based Decisions on the use of noninvasive ventilation with neonates
Basic principles of MRI machine. effect of mri on monitoring equipments in anesthesia. modes of anesthesia for MRI procedures.safety measures to be taken for MRI procedures
Anaesthesia challenges in neonatal emergencies-1.pptxsouravdash24
Neonatal emergencies present unique challenges in anesthesia, requiring specialized knowledge and skills to ensure safe and effective care for these vulnerable patients. This presentation delves into the intricacies of providing anesthesia to neonates in emergency situations, discussing physiological differences, equipment considerations, medication dosages, and monitoring techniques tailored to this population. Explore essential strategies and best practices for managing airway, ventilation, and hemodynamic stability in neonatal emergencies, aiming to optimize outcomes and mitigate risks. Whether you're a seasoned anesthesiologist or a healthcare professional seeking insight into neonatal anesthesia, this presentation offers valuable insights into navigating the complexities of neonatal emergencies with confidence and expertise.
Presentation of Dr. Dean Hess at 10th Pulmonary Medicine Update Course, Cairo, Egypt. Pulmonary Medicine Update Course is organized by Scribe : www.scribeofegypt.com
Introduction of organ donation .
Introduction of brain death and pathophysiology following it.
Perioperative problems in organ retrieval .
Goals of management of these patients .
Anesthetic management of the cadaver during organ harvesting.
This gives a brief idea about the:
Techniques, Response To NIV, Clinical indications, Contraindications and Evidence Based Decisions on the use of noninvasive ventilation with neonates
Basic principles of MRI machine. effect of mri on monitoring equipments in anesthesia. modes of anesthesia for MRI procedures.safety measures to be taken for MRI procedures
Anaesthesia challenges in neonatal emergencies-1.pptxsouravdash24
Neonatal emergencies present unique challenges in anesthesia, requiring specialized knowledge and skills to ensure safe and effective care for these vulnerable patients. This presentation delves into the intricacies of providing anesthesia to neonates in emergency situations, discussing physiological differences, equipment considerations, medication dosages, and monitoring techniques tailored to this population. Explore essential strategies and best practices for managing airway, ventilation, and hemodynamic stability in neonatal emergencies, aiming to optimize outcomes and mitigate risks. Whether you're a seasoned anesthesiologist or a healthcare professional seeking insight into neonatal anesthesia, this presentation offers valuable insights into navigating the complexities of neonatal emergencies with confidence and expertise.
Multisystem inflammatory syndrome with covid 19 in pediatricsMounika Bhallam
Multisystem Inflammatory Syndrome with COVID-19 in pediatrics:- this topic will make u to get knowledge in MISC condition in children and management of covid child with MISC along with Nursing care
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
3. • Neonatal surgical emergencies are common
in developing countries.
– High birth rate
– Consanguinity
– Infections during pregnancy
– Multiple pregnancies
– malnutrition
4. Some terminologies:
• Fetus: intrauterine period
• Newborn: upto 12 hrs after birth
• Neonate: upto 30 days after birth
• Infant: first 12 months of age.
• Gestational age:time from conception to
birth
• Post-natal age:time from birth to present time
• Post-conceptual age:from conception to present
age (G.A+post natal age)
5. CNS
• Gets 1/3rd of CO
• Autoregulation present, but not effective
• Myelination incomplete, senses are active
• Can feel pain , can smell & hear
• Blood – brain barrier
– Immature,hydrophilic & lipophilic cross the barrier
– Autonomic regulation good
– Parasympathetic domination
– Less number of receptors & variant protein binding
6. CNS…..
• InterVentricular hemorrhage:
– Surgical stimulation,
– inadequate analgesia,
– Airway instrumentation,
– Excessive transfusion,
prematures are more prone,
stressed neonate lacks autoregulation,
Fluctuations in CPP
7. CVS
• Heart contractile mass 30%,
• Ventricles less compliant,
• CO 350- 400ml/kg/mt.
• CO depends on heart rate & SV
• O2 consumption is 7 ml/kg/mt.
• Bradycardia is due to hypoxia, low CO,
vagal stimulation in anesthesia
8. AUTONOMIC NERVOUS SYSTEM
• Baroreceptors are immature & sensitive to
anesthetics
• Sympathectomy due to spinal or epidural-
no fall in B.P.(as sympathetic system is
immature).
• Fall of BP & HR due to sympathetic
blockade is offset by inhibition or
withdrawal of cardiac vagal activity.
9. RESPIRATORY SYSTEM
• Neonate has a large head, small weak
neck,obligate nose breather, large tongue,
U-shaped epiglottis,
funnel shaped larynx,
Subglottic portion is the narrowest
larynx is anterior & cephalad
cricoid is complete ring,
tracheal length is 2-5 cms.
10. • Respiratory centre is immature & sensitive to
depressant drugs
• More in prematures, apnoeic episodes are
common
• Lung volumes
– Tidal volume is small, 6 ml/kg 15 ml/kg
– O2 consumption is 7-9 ml/kg
– Resp.rate & alveolar vent. 2-3 times adult.
– FRC/VA ratio in neonates is 0.23,
– Changes in FiO2 causes rapid changes in oxygenation,
– MV/FRC is 5:1
– Less number of underdeveloped alveoli, surfactant less
– Ventilation is better controlled in infants < 3/12 of age
11. BLOOD
• Hb 18-19 gm/dl.
• PCV 60%
• Fetal Hb 70-90%
• ODC shifted to left
• Blood volume 80 ml/kg
• Cardiac index ,i.e CO/BSA is more
13. Metabolism & Thermal
Homeostasis
• O2 consumption is 7 ml/kg/mt – 7th day
• Temperature control is the most imp.
Consideration in pediatric anesthesia
• Metabolism drives MV & CO by increasing rate.
• Resting energy requirements is double that of
older child.
• Glucose is primay substrate for heart & brain
14. Metabolism & Thermal Homeostasis……
• Neonate has core temp. of 370C
– Increasing metabolic demands,
– Decreased stored carbohydrates,
– Decreased liver function,
– Increasing tendency to hypoglycemia
– Heat production by non shivering mech.
16. Fluid & Electrolyte Balance
• Initial fluid replacement must be low
• Overhydration can cause pulmonary edema
• Neonate requires Na: 2-3 meq/kg/day
• K : 2-3meq/kg/day
• Hypocalcemia is common in premature, sick &
acidotic
• Daily maintenance of Ca 500mg/kg/day
• Hypoglycemia is common in prematures
< 20mgs/dl
17. PAC & OPTIMISATION
• Keep in mind
– Neonatal problems
– Surgical problems
– Associated congenital problems
• Maintain
– Clear airway
– O2 therapy to achieve PaO2 of 50-70mm.Hg
– Stomach decompression
– Keep the baby warm at 370 C.
– I.V.line
– Correct acidosis if pH is < 7.3 with soda bicarb.
1-2meq/kg, slow infusion over 10-30 mts.
18. PAC & OPTIMISATION…..
– Ventilate if PaCO2 is > 50mm.Hg.
– Correct dehydration ( crystalloids),
• Insensible loss
• GI losses
• Others
– Correct hypovolemia ( colloids)
• Albumin, plasma, RBC, & whole blood if
necessary.
– Arterial line in critically ill patients.
19. MONITORING
• Precordial stethoscope or esophageal steth.
• ECG lead II
• BP cuff, oscillometer, arterial cath
• CVP – int.jugular, cubital vein
• Temp., thermister probe –
rectal,esophageal
or nasopharyngeal
20. MONITORING…..
• Ventilation
– Airway pr.monitoring,
– O2 analyser
– Mass spectrography
– Infra red capnograph
• Blood gases-
– SPO2, ETCO2, blood glucose & electrolytes
21. MONITORING…..
• Blood loss
– Small vol.suction traps,
– Swab weighing,
– Serial Hct estimation
• Urine volume
– Urinary catheter & collecting bag
• Above all, trained anesthesiologists eyes , hands &
ears are indispensible.
22. ANESTHESIA
• Major decision is whether or not the neonate needs
post-op ventilation & resuscitation.
• If post-op ventilation is needed, anesthesia
technique is of little importance, any tech. which
maintains BP & oxygenation is acceptable.
• If extubation is planned, anesthesia tech. is very
crucial.
• GA + Regional tech. with epidural Bupivacaine
0.25 %, 1 ml./kg with adrenaline is good.
23. ANESTHESIA….
• Regional block reduces doses of muscle relaxants,
narcotics & recovery will be good.
• Post-op pain relief can be planned
• All new borns must be intubated unless it is a
very minor procedure
• Consider them always ‘full stomach’
• Rapid sequence induction- no need of priming
with NDMR before DM. No fasciculations, no rise
of pressure with DMR.
24. INDUCTION
• It is to eliminate stress,
• CVS stability,
• To secure airway & ventilation,
• To prevent aspiration.
• Gastric pH at birth is 6.0; after 6 hrs. it is
2.5
25. INTUBATION
• It can be awake, or anesthetised.
• Indications for awake intubation:
– Very sick patients
– Anesthesiologist inexperienced in pediatric
anesthesia
– H/o apnoea or respiratory distress,
– Full stomach.
26. INTUBATION…..
• Complications of awake intubation:
– Arterial hypertension,
– IVH
– Apnoea,
– Obstruction to breathing,
– Desaturation & bradycardia
• Deep inhalational induction & 2% xylocaine spray
followed by intubation
• Intubation after paralysing with SUXA 2mg/kg
(controversial) , or NMDR & cricoid pressure.
27. INTUBATION…..
• Preoxygenation for 2 mts.is a must,
uncuffed ET , 20-40 cm/H2O pressure, no
pillow under the head & head extended.
• MAINTENANCE:
• Good oxygenation, prevention of stress due to pain
by short acting narcotics, intermittent inhalational &
muscle relaxants.
28. Maintenance…
– Intra – op fluid therapy:
• 0.2 % saline with 5% dextrose closely resembles the
obligatory fluid of neonate
• 4 ml/kg/hr. ( hyponatremia if given more)
• Better to use 0.45 % saline c 5% Dx.
• RL for 3rd space losses
• More 5% Dx causes hyperglycemia which leads to IVH due to
diuresis, cell dehydration & severe hyperosmolality.
• 5% Dx should not exceed 15-20ml/kg
• Serial estimation of glucose is necessary.
29. Maintenance…
• 3rd space losses in NEC, Omphalocele &
gastroschisis can exceed patients blood volume.
• CDH , congenital heart patients may not tolerate
larger vol.
• Interstitial edema develops
• Serial estimation of Hct , proteins , osmolality ,
electrolytes & urine output help in accurate
replacement of fluids.
• Neonate can tolerate 10% of blood loss
• Transfusion reactions like coagulation defects,
temp. changes, metabolic problems occur early in
neonates
30. RECOVERY
• Recovery is quick ,
• Extubation without good recovery causes
laryngeal spasm,
• Rx with IPPV , head extension , mandible thrust.
• If desaturation occurs ( < 85% ) IV suxa &
intubation.
• Don’t wait for cyanosis & bradycardia!
• Strong inspiratory efforts c obstruction causes pul.
edema,
• NMJ block must be reversed fully until active
movements of all 4 limbs occur
• Temp. must be > 35 0 C before reversal.
31. POST-OP PERIOD
• Most vulnerable period ,
hypoxia ,
laryngospasm &
cardiac arrest are common.
• Respiratory depression: Due to
– Apnoea
• Prematurity , narcotics , anesthetics , incomplete reversal ,
hypothermia , concomitant antibiotics &
hypermagnesemia –(PIH)
apnoea is more common below 41 weeks of PCA
upto 4th mth.
32. POST-OP PERIOD…
Hypoxemia due to
– Hypothermia , sepsis & acidosis.
• Rx:
FiO2 for 1st 24 hrs., monitor SaO2
• In conditions c reduced FRC like peritonitis,
int.obstruction, massive transfusions, correction of
omphalocele & gastroschisis-
minimum of CPAP should be provided
33. POST-OP PERIOD…
• Pre-op lung problems like RDS , pulmonary
dysplasia needs active ventilation.
• NMJ transmission impairment
• Hypotension may be due to hypovolemia or
residual inhalational agents
• Metabolic complications: hypocalcemia,
hypo & hyperglycemia.